 | Protalix BioTherapeutics, Inc. | |||
| ASE : PLX || Location: Israel | ||||
$1.18-0.03 (-2.48%) |
0.19 M | 1.16 - 1.22 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 6.704 M |
| March 28, 2024 | 6.461 M |
| March 15, 2024 | 6.674 M |
| Feb. 29, 2024 | 6.436 M |
| Feb. 15, 2024 | 6.152 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.03 | -0.07 | -131.02% |
| 09/30/2023 | -0.07 | -0.04 | 43.42% |
| 06/30/2023 | -0.04 | 0.21 | 619.80% |
| 12/31/2022 | -0.15 | -0.07 | 53.30% |
| 09/30/2022 | -0.15 | -0.07 | 53.30% |
PLX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 73.052M | Shares Float | 64.484M |
| Short Float | 6.704M | Market Cap | 88.39M |
| Institution ownership | 13.90% | Insider ownership | 9.769% |
| Earnings Date | 05/02/2024 BMO | Cash Per Share | ? |
| Trailing EPS | 0.09 | Forward EPS | 0.81 |